Syndrome of inappropriate antidiuretic hormone associated with vinorelbine therapy

Annals of Pharmacotherapy

Volumn 32, Issue 12, 1998, Pages 1306-1309

  Garrett, Clifford A ^a  

^a Redmond Regional Medical Center   (United States)

Author keywords

Breast cancer; SIADH; Vinca alkaloids; Vinorelbine

Indexed keywords

CATHARANTHINE; DEMECLOCYCLINE; NAVELBINE; POTASSIUM; SODIUM;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CASE REPORT; FEMALE; HUMAN; HYPOKALEMIA; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; KIDNEY FUNCTION; PRIORITY JOURNAL; PROPHYLAXIS; SEROLOGY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; FEMALE; HUMANS; INAPPROPRIATE ADH SYNDROME; MIDDLE AGED; POTASSIUM; SODIUM; VINBLASTINE;

EID: 0032443851     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.17278     Document Type: Article

References (4)

1. Hohneker JA. A summary of vinorelbine (Navelbine) safety data from North American clinical trials. Semin Oncol 1994;21(5 suppl 10):42-7.
2. Escuro RS, Adelstein DJ, Carter SG. Syndrome of inappropriate secretion of amidiuretic hormone after infusional vincristine. Cleve Clin J Med 1992;59:643-4.
3. Kosmidis HV, Bouhoutsou DO, Varvoutsi MC, Papadatos J, Stefanidis CG, Vlachos P, et al. Vincristine overdose: experience with 3 patients. Pediatr Hematol Oncol 1991;8:171-8.
4. Fraschini G, Recchia F, Holmes FA. Syndrome of inappropriate antidiuretic hormone secretion associated with hepatic arterial infusion of vinblastine in three patients with breast cancer. Tumor 1987;73:513-6.